Oriflame Announces Scientific Insights On Oripeptide-3 Technology

New scientific findings from Oriflame reveal that Oripeptide-3, the brand’s patented bioactivating technology and the core of the NovAge+ range, directly supports five key biological drivers of skin ageing. This discovery represents a significant advancement in Oriflame’s long-term research into skin longevity, cellular health and the science of ageing well.

Developed over nearly twenty years, Oripeptide-3 is designed to work with the skin’s natural biology to help extend its health and functional lifespan. The latest research highlights the technology’s positive impact on core skin longevity markers, strengthening the foundation for healthier, more resilient and youthful-looking skin.

Oripeptide-3 works across five recognised hallmarks of ageing by supporting the reactivation of aged cells and improving overall skin function, helping protect DNA integrity to contribute to better firmness and elasticity, maintaining protein quality to reduce oxidative stress and enhance radiance, supporting natural cellular renewal for improved clarity and vitality, and boosting the cellular energy required for repair, renewal and daily defence.

“Longevity is rightly the next frontier in beauty and we are proud to be leading this transformation with our skin longevity research at the molecular and cellular level,” said Lene Visdal-Johnsen, PhD, Director, Scientific Research and Innovation, Oriflame Global R&D.

“As consumers increasingly look for solutions that work deeper and deliver long-term skin benefits, innovations like Oripeptide-3 reflect our focus on advanced research and future-ready skincare,” said Edyta Kurek, Senior Vice President & Head, Oriflame India and Indonesia.

With these findings, Oriflame strengthens its position in advanced skin biology, reaffirming its commitment to innovation that supports long-term skin health and performance.